Diabetes & Metabolism

Article	Citations
Contents - page 1	131
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France	122
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study	82
Editorial board	62
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report	45
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department	41
Overview of the major clinical trials investigating stem cells–based therapies for diabetes	38
Factors impacting the recent doubling of French hyperglycaemia prevalence in pregnancy	36
Are GLP-1 receptor agonists and diabetic retinopathy foes or friends?	35
Contents	34
Editorial board	32
Association between adipose deposition and mortality among adults without major cardiovascular risk factors	30
Reduced risks of colorectal cancer with GLP-1RAs in type 2 diabetes: A nationwide cohort study using a target trial emulation framework	29
The significance of ophthalmological evaluation in the correct diagnosis of pediatric insulin-dependent diabetes mellitus: lessons from novel WFS1 variants	29
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood	28
Body weight trends in individuals with type 1 diabetes using automated insulin delivery vs. traditional insulin pumps	27
Pancreatic polypeptide in patients with type 1 diabetes and exocrine failure or chronic pancreatitis. The DIAPP study	26
Diabetic retinopathy remission in patients using an automated insulin delivery system: A prospective controlled study	26
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients	25
Management of dyslipidemia in adults. A consensus statement from the French Society of Endocrinology (SFE), the French-speaking Diabetes Society (SFD), the New French-speaking Atherosclerosis Society	25
Bedside amputation surgery for isolated toe necrosis in diabetes units as an alternative to conventional amputation in surgery units	24
Telemedicine-based diabetic retinopathy screening in patients over 70 Years: a French cohort study within the OPHDIAT network	24
Glucagon-like peptide-1 receptor agonists and the risk of nonarteritic anterior ischemic optic neuropathy: Evidence from a global real-world cohort	23
Editorial board	21
Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations	20

Concise review of lipidomics in nonalcoholic fatty liver disease	20
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes	19
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–2021	19
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes	19
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review	19
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–2020	19
Contents	18
Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study	17
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis	17
Type B insulin resistance syndrome: A case report	17
Contents	17
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability	16
Contents	16
Contents	16
Modelled substitution of meat with dairy products and the 20-year cumulative incidence of type 2 diabetes: Insights from the ATTICA cohort study (2002–2022)	16
1-h post-load plasma glucose for detecting early stages of prediabetes	16
No association between carbohydrate-counting knowledge and disordered eating behaviors in adults with type 1 diabetes	15
Efficacy and safety of pharmacological treatments for gestational diabetes: a systematic review comparing metformin with glibenclamide and insulin	14
Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study	14
Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999-2018	14
Correspondence for “Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring”	14
Averaged glycaemic variability or by average: More than a simple question of wording	14
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes	13
Glucose management indicator: Do we need device-specific equations?	13
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications	13
Editorial board	13
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT	13
Editorial board	12
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction	12
Fracture risk and treatment thresholds in patients with diabetes	12
Contents	12
Monitoring gestational diabetes mellitus patients with myDiabby Healthcare® smartphone application vs classical diary. Results from the non-inferiority TELESUR-GDM study	12
Conduction disturbances in Type 1 and Type 2 Diabetes in two large independent nationwide and international databases	12
Peripheral neuropathy as a bedside marker for cerebral microangiopathy	12
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention	12
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease	12
Contents - Page 1	12
Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study	12
Diabetes prevalence, awareness, and control in the United States, 2017-2023	12
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus	12
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus	11
"Usefulness of continuous interstitial glucose in diabetic patient undergoing hemodialysis	11
Association of podocyte ultrastructural changes with proteinuria and pathological classification in type 2 diabetic nephropathy	11
Glucagon like peptide-1 receptor agonists in type 1 diabetes	11
Contents - page 1	11
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV rand	11
Contents	10
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals	10
Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance	10
Editorial board	10

Association between smoking status and suicide mortality in patients with type 2 diabetes: A nationwide population-based cohort study	10
Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease	10
Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults	10
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study	10
Editorial board	10
Secukinumab (Anti-IL-17) induces clinical regression in early diagnosed type 1 diabetes: A case report	9
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus	9
Impact of different types of hypertensive disorders of pregnancy and their duration on incident post-partum risk of diabetes mellitus: Results from the French nationwide study CONCEPTION	9
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus	9
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis	9
BMD: Toward mechanistically-informed and fracture-specific treatment thresholds in diabetic bone disease	9
Is Omnipod 5 cost effective for the management of type 1 diabetes among adults in France?	9
Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort	9
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists	9
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography	9
Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders	9
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States	9
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan	9
Effect of dietary reinforcement combined or not with GLP-1 receptor agonist therapy on histological outcomes in MASLD among patients with type 2 diabetes	9
Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: A population-based cohort study	8
SGLT2 inhibitor and urothelial carcinoma incidence in type 2 diabetes patients	8
Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes	8
Editorial board	8
Automated insulin delivery for people living with Type 1 Diabetes in France: A long road ahead	8
Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?	8
Characteristics of newly diagnosed type 1 diabetes in paediatric and adult population from Reims University Hospital, France from 1997 to 2019	8
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial	8
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors	8
Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease	8
Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch	7
Contents	7
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study	7
Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies	7
Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study	7
Excess burden of hospitalizations in adults with diabetes – a national US cross-sectional study	7
Treatment of women with mild gestational diabetes mellitus decreases the risk of adverse perinatal outcomes	7
Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus	7
Trajectories of social isolation and loneliness and the risk of incident type 2 diabetes mellitus across genetic risk score	7
Patient-reported outcome measures (PROMs) are differently associated with treatment modalities, household income, and diabetes-related events in children with type 1 diabetes, their mothers, and their	7
Bone phenotype in familial partial lipodystrophy type 2: insulin resistance and sclerostin	7
Serum albumin and risk of incident diabetes and diabetic microvascular complications in the UK Biobank cohort	7
Impact of chronic emotions and psychosocial stress on glycemic control in patients with type 1 diabetes. Heterogeneity of glycemic responses, biological mechanisms, and personalized medical treatment	7
Reproductive factors, genetic susceptibility and risk of type 2 diabetes: A prospective cohort study	7
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors	6
Association between diabetes and stress-induced hyperglycemia with skeletal muscle gene expression of INSR in critically ill patients: A prospective cohort study	6
The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort survey	6
Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus	6
GLP-1-derived therapies and sarcopenia: plea for a specific focus on at risk special populations	6
Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study	6
Increased risk of renal events in people with diabetic foot disease: A longitudinal observational study	6
Exploring perceived barriers to physical activity among individuals with type 1 diabetes in the era of new technologies: An analysis from the BETTER registry	6
Association between blood urea nitrogen-to-creatinine ratio and insulin sensitivity	6
Do GLP1-receptor agonists actually cause non-arteritic anterior ischemic optic neuropathy?	6
Contents	5
Low hemoglobin, even within the normal range, is associated with diabetic kidney disease	5
Leisure-time physical activity and mortality risk in type 2 diabetes: A nationwide cohort study	5
A very rare cause of markedly elevated CA 19–9: Glucagon-like peptide-1 receptor agonists	5
The association between primary bile acids and metabolically unhealthy obesity	5
Editorial board	5
When “good” comes too fast: rapid glycemic correction and the kidney: a “metabolic descent” hypothesis	5
Non-dioxin-like polychlorinated biphenyls (NDL-PCBs) dietary exposure is associated with an increased risk of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC)	5
Phthalates exposure, biological aging, and increased risks of insulin resistance, prediabetes, and diabetes in adults with metabolic dysfunction-associated steatotic liver disease	5
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes	5
Epicardial adipose tissue measurement is an interesting biomarker for cardiovascular health in a case control study of patients with familial partial type 2 lipodystrophy	5
Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring	5
Impaired auditory neural performance, another dimension of hearing loss in type-2 diabetes mellitus	5
Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database	5
Post-translational modifications of apolipoproteins as promising biomarkers for diabetes-related cardiovascular diseases: A comprehensive review	5
Addition of fenofibrate to statins is associated with risk reduction of diabetic retinopathy progression in patients with type 2 diabetes and metabolic syndrome: A propensity-matched cohort study	4
Glucagon-like peptide-1 receptor agonists and acute pancreatitis	4
High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes	4
Association between gastrectomy and the risk of type 2 diabetes in gastric cancer survivors: A nationwide cohort study	4
Comment on Orsi et al. Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes [Diabetes Metab, 2023 Mar, 101413]	4
Overweight and risk of type 2 diabetes: A prospective Chinese twin study	4
Editorial board	4
Microalbuminuria screening in patients with ST-elevation myocardial infarction	4
Relationship of ultra-processed food consumption and new-onset chronic kidney diseases among participants with or without diabetes	4
Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study	4
Editorial board	4
Regular use of ibuprofen or paracetamol and incident type 2 diabetes: A prospective cohort study in the UK Biobank	4

Editorial board	4
Circulating levels of GDF-15 for predicting cardiovascular and cancer morbidity and mortality in type 2 diabetes: Findings from Da Qing IGT and Diabetes Study	4
Comparative cardiovascular effectiveness of GLP-1RAs versus DPP-4is in dialysis patients with type 2 diabetes: a target trial emulation	4
Persistent gaps in the implementation of lipid-lowering therapy in patients with established atherosclerotic cardiovascular disease: A French nationwide study	4
Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study	4
Editorial board	4
Gut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss	4
Early varicella infection is associated with a delayed onset of childhood type 1 diabetes	4
β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months	4
Smoking and diabetes interplay: A comprehensive review and joint statement	3
Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease	3
Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies	3
Closed-loop insulin delivery systems in patients with pancreatitis or pancreatectomy-induced diabetes: A case series	3
Prediction of cardiovascular events by skin auto-fluorescence: the DIABAGE follow-up study	3
Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes	3
Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks	3
Key indices of glycaemic variability for application in diabetes clinical practice	3
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study	3
Hip fractures and type 2 diabetes in the elderly: Risk factors analysis of the Nedices cohort	3
Practical implementation of automated insulin delivery systems in 2025: A French position statement update	3
Management of patients with type 2 diabetes and MASLD: An overview and joint statement	3
Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes Society	3
The association of sweetened beverage intake with risk of type 2 diabetes in an Australian population: A longitudinal study	3